213 related articles for article (PubMed ID: 37354812)
1. Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications.
Wu S; Li R; Jiang Y; Yu J; Zheng J; Li Z; Li M; Xin K; Wang Y; Xu Z; Li S; Chen X
Biomed Pharmacother; 2023 Sep; 165():115027. PubMed ID: 37354812
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsies for detection, surveillance, and prognosis of urothelial cancer: a future standard?
Duquesne I; Abou Chakra M; Hage L; Pinar U; Loriot Y
Expert Rev Anticancer Ther; 2023; 23(9):995-1007. PubMed ID: 37542214
[TBL] [Abstract][Full Text] [Related]
3. Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.
Rose KM; Huelster HL; Meeks JJ; Faltas BM; Sonpavde GP; Lerner SP; Ross JS; Spiess PE; Grass GD; Jain RK; Kamat AM; Vosoughi A; Wang L; Wang X; Li R
Nat Rev Urol; 2023 Jul; 20(7):406-419. PubMed ID: 36977797
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of urothelial cancer disease status after treatment by digital droplet PCR liquid biopsy assays.
Pritchard JJG; Hamilton G; Hurst CD; Fraser S; Orange C; Knowles MA; Jones RJ; Leung HY; Iwata T
Urol Oncol; 2020 Sep; 38(9):737.e1-737.e10. PubMed ID: 32532529
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
[No Abstract] [Full Text] [Related]
6. Detection of pagetoid urothelial intraepithelial neoplasia extending to the vagina by cervical screening cytology: a case report with renewed immunochemical summary.
Koyanagi Y; Kubo C; Nagata S; Ryu A; Hatano K; Kano R; Tanada S; Ashimura JI; Idota A; Kamiura S; Yamasaki T; Nakatsuka SI
Diagn Pathol; 2019 Feb; 14(1):9. PubMed ID: 30711015
[TBL] [Abstract][Full Text] [Related]
7. Changes in Urinary Exosomal Nuclear Matrix Protein-22 in Dogs With Urothelial Carcinoma: A Pilot Study.
Shin JH; An JH; Park SM; Lim GH; Seo KW; Youn HY
In Vivo; 2024; 38(1):190-195. PubMed ID: 38148062
[TBL] [Abstract][Full Text] [Related]
8. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of semaphorin 3A in patients with urothelial cancer.
Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis of urothelial carcinoma].
Karl A; Zaak D; Tilki D; Hungerhuber E; Staehler M; Denzinger S; Stanislaus P; Tritschler S; Strittmatter F; Stief C; Burger M
Urologe A; 2008 Mar; 47(3):357-67. PubMed ID: 18274722
[TBL] [Abstract][Full Text] [Related]
12. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
[TBL] [Abstract][Full Text] [Related]
13. Detection of Copy Number Imbalance in Canine Urothelial Carcinoma With Droplet Digital Polymerase Chain Reaction.
Mochizuki H; Shapiro SG; Breen M
Vet Pathol; 2016 Jul; 53(4):764-72. PubMed ID: 26574558
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
Zeuschner P; Linxweiler J; Junker K
Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
[No Abstract] [Full Text] [Related]
15. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
16. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
17. Detection of HPV infection in urothelial carcinoma using RNAscope: Clinicopathological characterization.
Musangile FY; Matsuzaki I; Okodo M; Shirasaki A; Mikasa Y; Iwamoto R; Takahashi Y; Kojima F; Murata SI
Cancer Med; 2021 Aug; 10(16):5534-5544. PubMed ID: 34164940
[TBL] [Abstract][Full Text] [Related]
18. Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
Yang K; Hu H; Wu J; Wang H; Guo Z; Yu W; Yao L; Ding F; Zhou T; Wang W; Wang Y; Liu L; Guo J; Zhu S; Zhang X; Cao S; Lou F; Niu Y; Ye D; He Z
Mol Cancer; 2023 Feb; 22(1):25. PubMed ID: 36739413
[TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer.
Chalfin HJ; Glavaris SA; Gorin MA; Kates MR; Fong MH; Dong L; Matoso A; Bivalacqua TJ; Johnson MH; Pienta KJ; Hahn NM; McConkey DJ
Eur Urol Oncol; 2021 Apr; 4(2):310-314. PubMed ID: 31563523
[TBL] [Abstract][Full Text] [Related]
20. Unbiased enrichment of urine exfoliated cells on nanostructured substrates for sensitive detection of urothelial tumor cells.
Wang X; Gu Y; Zhang S; Li G; Liu T; Wang T; Qin H; Jiang B; Zhu L; Li Y; Lei H; Li M; Zhang Q; Yang R; Fang F; Guo H
Cancer Med; 2020 Jan; 9(1):290-301. PubMed ID: 31709750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
